ÂÜÀòÂÒÂ×

Sophie Teng has over a decade of experience in pharmacokinetics and clinical pharmacology. Currently serving as a Pharmacokinetic and Interactions assessor at the French Medicine Agency since November 2018, responsibilities include European Centralized MAA submissions and drug-drug interaction assessments. Prior to this role, Sophie worked at ADOCIA as a research scientist, focusing on the design and analysis of preclinical and clinical studies. Sophie's earlier experience includes a PhD candidacy at INERIS, where in silico models were developed for assessing hepato-toxicity of cosmetic mixtures, and a clinical pharmacology residency at APHP, where PK/PD modeling was utilized for dosing recommendations in neonates. Educational qualifications include a PhD in Toxicology from AgroParisTech and a Master's degree in Pharmacokinetics and Doctor of Pharmacy from Université Paris Cité.